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ABSTRACT
Background. This article presents prospective longitudinal findings on prevalence, incidence,
patterns of change and stability of depressive disorders in a community sample of 1228 adolescents.
Methods. Data were collected at baseline and follow-up (20 months later) in a representative
population sample of 1228 adolescents, aged 14–17 at baseline. Diagnostic assessment was based on
the Munich Composite International Diagnostic Interview (M-CIDI).
Results. The overall cumulative lifetime incidence of any depressive condition was 20±0% (major
depressive disorder (MDD), 12±2%; dysthymia, 3±5%; subthreshold MDD, 6±3%), of which about
one-third were incident depressions in the period between baseline and follow-up. Depressive
disorders rarely started before the age of 13. Females were about twice as likely as males to develop
a depressive disorder. Overall, the 20-month outcome of baseline depression was unfavourable.
Dysthymia had the poorest outcome of all, with a complete remission rate of only 33% versus 43%
for MDD and 54% for subthreshold MDD. Dysthymia also had the highest number of depressive
episodes, and most psychosocial impairment and suicidal behavioural during follow-up. Treatment
rates were low (8–23%). Subthreshold MDD associated with considerable impairment had an
almost identical course and outcome as threshold MDD.
Conclusions. DSM-IV MDD and dysthymia are rare before the age of 13, but frequent during
adolescence, with an estimated lifetime cumulative incidence of 14%. Only a minority of these
disorders in adolescence is treated, and more than half of them persist or remit only partly.
INTRODUCTION
Over the past decade, various community studies
reported that depression is a frequently oc-
curring mental disorder among adolescents.
However, estimated prevalence rates for DSM
major depressive disorder (MDD) in this age
group (roughly defined as 14–19 years) show
considerable variation. Lifetime prevalences
range from 4% (Whittaker et al. 1990) to 24%
(Lewinsohn et al. 1993), 1-year prevalences from
4% (Fergusson et al. 1993) to 17% (Feehan et
al. 1994) and point prevalences from 3%
" Address for correspondence: Dr A. J. Oldehinkel, Max Planck
Institute of Psychiatry, Clinical Psychology and Epidemiology Unit,
Kraepelinstrasse 2, 80804 Mu$ nchen, Germany.
(Lewinsohn et al. 1993; Feehan et al. 1994) to
6% (Blazer et al. 1994). This variation is assumed
to be mainly due to differences in assessment
instruments and diagnostic criteria of depressive
disorders, sampling and design, and to the time
the respective study was conducted (Kovacs &
Gatsonis, 1994). The recent American Academy
of Child and Adolescent Psychiatry consensus
(AACAP, 1998) estimated the prevalence of
MDD in adolescents to be 4–8%, and the
cumulative incidence by the age of 18 to be
approximately 20%, based on the study by
Lewinsohn et al. (1993).
Rates of depressive disorders in childhood
(defined as below the age of 14) were found to be
considerably lower. Findings suggest that it is
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only after the age of 13 that cumulative
incidences rise sharply, with peak incidences
between ages 15 and 18 (Fleming et al. 1989;
Burke et al. 1990; Fleming & Offord, 1990;
Lewinsohn et al. 1992; Kessler et al. 1993;
Hankin et al. 1998; Steinhausen et al. 1998).
However, when evaluating prevalence rates and
age-of-onset characteristics of depressive dis-
orders in the transition period from childhood
to adolescence, we need to acknowledge some
potential assessment problems. In the first place,
standardized diagnostic interviews for adults,
such as the Composite International Diagnostic
Interview (CIDI, WHO, 1990), the Diagnostic
Interview Schedule (DIS, Robins et al. 1981)
and the Schedule for Affective Disorders and
Schizophrenia (SADS, Orvaschel et al. 1982)
appear to work well in persons over 14 years of
age, but it is generally agreed that younger
children may need different assessment stra-
tegies, such as the Diagnostic Interview Schedule
for Children (DISC, NIMH, 1992) and the
Child and Adolescent Psychiatric Assessment
(CAPA, Angold et al. 1995). Parents or teachers
are normally used as (additional) sources of
information. Furthermore, clinically valid diag-
noses of depression in children may require
slightly different diagnostic criteria. Although
Kovacs (1996) reported similar features of MDD
across juvenile and older patients in clinically
referred samples, the symptom presentation and
duration of depression may differ between
children and older persons in community
samples. The recent DSM-IV criteria for child-
hood MDD and dysthymia are consistent with
this in that mood may be irritable instead of
depressed, and that the duration of dysthymia
should be at least one year instead of two.
One could assume that the relative rarity of
childhood depression and prepubertal onsets in
most studies is an artefact of the strict criteria of
DSM, which may be appropriate in adults, but
not in children, and hence expect to find
considerably higher proportions of various
forms of MDD just falling short of diagnostic
criteria (defined as subthreshold MDD) in
children and (young) adolescents. In a study
among 9–13-year-olds, Costello et al. (1996a)
found that strictly diagnosed DSM-III-R diag-
noses were rare, but that there was a substantial
group of children who had the core symptoms of
mood disorder and anhedonia but did not reach
the criterion either for duration of dysthymia, or
for the number of symptoms of MDD. Similarly,
Cooper & Goodyer (1993) noted that a large
proportion of their sample of 11–16-year-old
girls reported depressive symptoms but did not
meet DSM-III-R criteria for MDD. Corre-
spondingly, some authors stress the importance
of assessing subsyndromal forms of depression
and hence favour the use of more lenient
diagnostic criteria (Lewinsohn et al. 1994;
AACAP, 1998). On the other hand, others
believe that the DSM-III(-R) criteria for MDD
may not be strict enough, as many adolescents
with DSM-III(-R) MDD seem to be functioning
adequately (Jensen et al. 1993; Verhulst et al.
1997). Therefore, Roberts et al. (1998) and
Costello et al. (1996b) recommend strongly the
use of both symptom and impairment criteria
when determining caseness. These ongoing dis-
cussions clearly signal the need for a broader
assessment of depressive disorders beyond
strictly defined DSM-IV criteria for MDD, by
using varying symptom and impairment criteria.
Exploration of subthreshold conditions might
offer guidance about more suitable diagnostic
threshold criteria for depression in (early)
adolescence.
Consistent with findings in adult depression,
epidemiological studies in adolescents revealed
that females are affected about twice as fre-
quently as males. Many studies reported
approximately the same rates for boys and girls
in children, and an increase in gender differences
in middle-to-late adolescence (Kashani et al.
1989; Burke et al. 1990; Petersen et al. 1993; Ge
et al. 1994; Birmaher et al. 1996; Angold et al.
1998; Hankin et al. 1998), although others failed
to find a significant age by gender interaction
(Lewinsohn et al. 1993; Simonoff et al. 1997).
These findings, as well as the many major
social and biological changes taking place in
adolescence, indicate that this period might be
crucial for our understanding of onset mech-
anisms of depressive disorders (Hankin et al.
1998). The ideal way to identify onset mech-
anisms and aetiological and pathogenetic impli-
cations are longitudinal studies in general popu-
lation samples, providing information about the
forms, severity, stability and incidence, as well
as about the outcome of depressive disorders in
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adolescence. Studies meeting those criteria are
still relatively rare (Roberts et al. 1998). More
knowledge about the nature of depression in
adolescents is also essential for various other
reasons: (a) adolescence is a period in which
subjects make important developmental choices,
which may be seriously affected by depressive
symptoms; (b) depressive symptoms can lead to
unfavourable consequences such as substance
abuse and impairment in interpersonal relation-
ships and global functioning (e.g. Birmaher et al.
1996) ; (c) early onset of depressive disorder
strongly increases the risk for recurrent de-
pressive disorders during adulthood (Harrington
et al. 1990; Rao et al. 1995; Kovacs 1996; Pine
et al. 1998). A better understanding of the
magnitude and form of adolescent depression,
its natural course and outcome may contribute
to setting more appropriate priorities for pre-
vention and treatment.
Aims
This paper reports findings from the Early
Developmental Stages of Psychopathology
(EDSP) Study, a large longitudinal population-
based survey of adolescents and young adults
(aged 14 and over) in Munich, Germany, which
focuses on three main areas, as follows.
1 The baseline and follow-up prevalence as
well as the 20-month incidence of mild, moderate
and severe forms of MDD, dysthymia, and
subthreshold MDD, which is defined as falling
short of one of the DSM-IV criteria for MDD.
2 Similarities and differences between
threshold and subthreshold MDD regarding
age-of-onset characteristics, course, and impair-
ment. We hypothesize that subthreshold MDD
is more likely to have an early (childhood) age of
onset and is more prevalent in early adolescence
than threshold MDD.
3 The symptom and diagnostic stability of
adolescent depressive disorder over the follow-
up period of 20 months, by examination of the
natural course and various symptom and psy-
chosocial outcome measures at follow-up.
Furthermore, we will examine similarities and
differences between two forms of subthreshold
MDD, namely subthreshold MDD falling short
of the required number of symptoms and
subthreshold MDD lacking the impairment
criterion.
METHOD
Sample
The data presented here were collected as part of
the Early Development Stages of Psychopath-
ology (EDSP) study, a research programme
funded by the German Ministry of Research
and Technology, whose mission is to study the
prevalence, incidence, risk factors, natural
course and interrelationships of a wide range of
mental disorders and substance abuse in ado-
lescents and young adults in a prospective way.
A detailed description of the methods used in
the EDSP study has been reported elsewhere
(Wittchen et al. 1998a, b). Very briefly, the
EDSP study involves a baseline (completed in
1995) and two follow-up surveys, the first of
which was completed in 1997. The sample was
drawn from the 1994 government registers of
residents in metropolitan Munich including the
more rural surrounding counties, from all
registrants expected to be 14–24 years old during
the first half of 1995. Because of the low birth
rate in the youngest age cohort and the aim of
Table 1. Distribution of sociodemographic
variables at baseline (weighted estimates)
%
Current educational status or employment
Hauptschule 8±9
Realschule 19±9
Fachhochschule 4±1
Gymnasium 57±0
University 8±4
Unemployed 0±9
Employed 0±8
Living arrangement
With both parents 74±8
With single parent 24±5
Alone 0±7
Social class
I lowest 0±1
II lower middle 4±4
III middle 62±2
IV upper middle 29±1
V upper 4±2
Subjective financial situation
Very bad 0±0
Bad 3±6
Not good, not bad 25±9
Good 57±2
Very good 13±3
Urbanicity
Suburbs 27±6
Central Munich 72±4
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having a sufficiently high number of cases
unaffected by mental disorders and psychotropic
substance abuse, persons aged 14–15 were
sampled at twice the probability of those aged
16–21, and 22–24-year-olds were sampled at half
this probability. The present analysis on ado-
lescent depression is restricted to respondents
aged 14–17 at baseline (N¯ 1395).
The baseline response rate among 14–17-year-
olds was 74±3%, and the first follow-up was
completed in 1228 cases (response rate 88±0%).
Although originally the follow-up investigation
was planned after a 12-month interval, this
turned out to be technically unfeasible because
of the sample size. Thus, the actual median time
interval between baseline and follow-up was
19±7 months, with a range of 14 to 24 months.
All data presented in this paper originate from
the respondents themselves, for whom both
individual and parents’ informed consent was
obtained. To account for the above-mentioned
differential sampling probabilities, individuals
who could not be located and refusal to
participate, the data have been adjusted by age,
gender and geographic location to match the
distribution to the original sampling frame. For
a more detailed description see Wittchen et al.
(1998a, b).
Table 1 shows the distribution of socio-
demographic variables at baseline. Almost all
subjects were attending school (90%) or uni-
versity (8%) and were living with their parents
(99%) at the time of the first interview. The
most frequent school type was the Gymnasium
(similar to high school), followed by the Real-
schule (an intermediate type of schooling) and
the Hauptschule (providing the mandatory 10-
year basic schooling). Only very few respondents
in this group were employed or unemployed.
The majority of the respondents were classified
as middle class (62%), reflecting the population
of Munich. Noteworthy changes in socio-
demographic characteristics from baseline to
follow-up were only found for school and
employment status, with 21% of the respondents
having changed to job training programmes.
Diagnostic assessment
Face-to-face computer-assisted interviews were
administered by professional health interviewers
and clinical psychologists at baseline and by
clinically trained interviewers only at follow-up.
Both at baseline and follow-up, diagnostic
assessment was based on the Munich version of
the Composite International Diagnostic Inter-
view (M-CIDI; Wittchen & Pfister, 1997). At
baseline the lifetime version of the M-CIDI was
used to compute DSM-IV (APA, 1994) diag-
noses over a period of the past 12 months and
lifetime (lifetime covering the past 12 months
and the period before). In the follow-up investi-
gation, the follow-up version of the M-CIDI
(Wittchen & Pfister, 1997) was used to evaluate
symptoms and diagnoses during the previous 12
months and the whole follow-up interval. The
M-CIDI is an updated version of the World
Health Organization’s CIDI version 1.2 (WHO,
1990), which incorporates questions to cover
DSM-IV and ICD-10 criteria. The M-CIDI
allows for the assessment of symptoms, syn-
dromes and diagnoses of 48 mental disorders,
supplemented with information about onset,
duration, clinical and psychosocial severity, and
health service utilization. Reliability and pro-
cedural validity findings for the M-CIDI have
been reported elsewhere (Lachner et al. 1998;
Reed et al. 1998; Wittchen et al. 1998c), along
with detailed descriptions of its format and
structure. Briefly, findings for depressive dis-
orders in a sample of 60 subjects aged 14–24
revealed a test–retest reliability (kappa) of 0±68
for MDD and 0±70 for dysthymia. Test–retest
reliability for age of onset of depressive disorders
was high for depressive episode (intraclass
coefficient¯ 0±97) and moderate for dysthymia
(intraclass coefficient¯ 0±60). Clinical validity
as compared to best estimates clinical infor-
mation was found to be excellent (kappa¯ 0±95,
base rate 26%) for MDD and moderate (kappa
¯ 0±54, base rate 10%) for dysthymia. The M-
CIDI DSM-IV algorithms allow for further
subtyping of single and recurrent episodes of
MDD by severity (mild, moderate, severe)
according to DSM-IV’s respective specific. Fur-
thermore, it is possible to compute a diagnosis
of subthreshold MDD, using the WHO-CIDI
algorithm (U$ stu$ n & Sartorius, 1995). This
diagnosis is assigned when respondents fall short
of just one diagnostic criterion, by failing to
report either the mandatory five of a total of
nine symptoms (criterion A). Or clinically
significant distress or impairment (criterion C).
In addition, we defined the category ‘sympto-
matic depression’ as the presence of at least two
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depression symptoms for at least 2 weeks, but
neither MDD nor dysthymia nor subthreshold
MDD. Unless otherwise stated, diagnostic
findings reported in this paper are based on the
M-CIDI DSM-IV algorithms without using the
exclusion criteria for dysthymia. According to
DSM-IV rules, the diagnosis of dysthymia can
only be made if the dysthymic disorder was
established at least 2 years prior to the first
major depressive episode (if any), or if there has
been a full remission of at least 2 months of the
major depressive episode before the onset of
dysthymia (APA, 1994). About 40% of the
respondents with dysthymia also had a lifetime
diagnosis of MDD and 16% met the DSM-IV
exclusion criteria. Other DSM-IV diagnostic
exclusions, however, were taken into account.
Thus, depressive syndromes fully accounted for
by bereavement, bipolar disorder, substance
disorder or general medical conditions were not
counted as depressive disorders throughout the
paper.
Measures
The following measures are used in this paper.
‘Baseline prevalence’ denotes the weighted rates
of occurrence of depressive disorders among
respondents aged 14–17 at baseline, reported
separately for disorders present during the 12
months preceding the interview and for disorders
present at least once during lifetime. ‘Incidence’
is defined as the proportion of the sample with a
new (incident) depression between baseline and
follow-up. ‘Twelve-month prevalence’ rates at
follow-up refer to DSM-IV criteria which were
met within the 12 months preceding the follow-
up interview. Finally, ‘cumulative lifetime pre-
valence’, or more accurately cumulative lifetime
incidence, is – in principle – calculated by adding
the diagnostic outcomes at baseline (lifetime
prevalence) and the incidence in the follow-up
period. However, since subthreshold MDD and
MDD were classified hierarchically, respondents
with a baseline diagnosis of MDD could not be
incident subthreshold cases, but a baseline
subthresholdMDDdid not exclude the incidence
of MDD between baseline and follow-up. In
other words, some of the baseline subthreshold
MDD cases turned into follow-up MDD cases.
Furthermore, a baseline case of mild depression
could turn into a follow-up case of moderate or
severe depression, and a baseline moderate case
could turn into a follow-up severe case, but the
opposite was not possible. Because of these
hierarchies, the cumulative lifetime incidence
not may be the sum of the lifetime prevalence at
baseline plus the incidence for subthreshold,
mild, moderate and severe MDD.
Statistical analysis
Unless indicated otherwise, data were weighted
to adjust for differential sampling probabilities,
non-contact and non-response. To account for
design effects introdued by the use of weighted
data, statistical tests on weighted data were
performed using the so-called svy (survey)
commands of the statistical program STATA
(StataCorp., 1997). A P value ! 0±05 was
considered statistically significant. Age-of-
onset curves (cumulative hazards) were calcu-
lated by means of Kaplan–Meier estimates
(Kaplan & Meier, 1958).
RESULTS
Selective drop-out
Of all respondents aged 14–17 at baseline (N¯
1395), the participation at follow-up was 88%
(N¯ 1228). The group who declined partici-
pation at follow-up did not differ from the
group who participated with respect to baseline
MDD (χ#
"
¯ 0±004, P¯ 0±95) and subthreshold
MDD (χ#
"
¯ 0±3, P¯ 0±57), but contained sig-
nificantly more persons with dysthymia (7±0%
versus 1±7%, χ#
"
¯ 12±9, P! 0±01). Furthermore,
the groups did not differ with regard to the
proportion with any DSM-IV anxiety disorder
(χ#
"
¯ 0±8, P¯ 0±37); or with obsessive–
compulsive disorder, post-traumatic stress dis-
order, somatization disorder, or eating disorder
(χ#
"
¯ 1±1, P¯ 0±30).
Prevalence and incidence
At baseline 13±0% of the sample (14–17 years
old) reported having had at least one of the
depressive conditions listed (Table 2). Dys-
thymia was found to be quite rare (1±7%); the
majority fulfilled criteria for either MDD
(6±7%), mostly of moderate or severe type, or
subthreshold MDD (5±3%). About half of the
baseline lifetime MDDs, two-thirds of the
subthreshold MDDs and almost all dysthymic
disorders were also ‘active ’ during the 12 months
preceding the interview, resulting in a 12-month
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Table 2. Weighted prevalence estimates with standard errors (S.E.) of M-CIDI DSM-IV depressive
conditions at baseline and follow-up, 20-month incidence and cumulative incidence among respondents
aged 14–17 years at baseline
Baseline
20-month
Follow-up
LT 12-month Incidence 12-month Cumulative LT
% (..) % (..) % (..) % (..) % (..)
Total group (N¯ 1228)
Subthreshold MDD 5±3 (0±7) 3±5 (0±6) 2±1 (0±4) 2±9 (0±5) 6±3 (0±7)
MDD 6±7 (0±8) 3±4 (0±6) 5±6 (0±7) 6±8 (0±8) 12±2 (1±0)
Mild 1±1 (0±3) 0±7 (0±3) 1±8 (0±4) 2±4 (0±5) 2±8 (0±5)
Moderate 2±4 (0±5) 1±1 (0±3) 2±0 (0±4) 2±3 (0±5) 4±2 (0±6)
Severe 3±2 (0±6) 1±7 (0±4) 1±7 (0±4) 2±1 (0±5) 5±2 (0±7)
Dysthymia 1±7 (0±4) 1±6 (0±3) 1±8 (0±4) 2±1 (0±5) 3±5 (0±6)
Any (including subthreshold) 13±0 (1±1) 8±0 (0±8) 7±1 (0±8) 11±1 (1±0) 20±0 (1±3)
Males (N¯ 619)
Subthreshold MDD 4±4 (0±9) 2±5 (0±7) 1±0 (0±4) 1±8 (0±7) 4±7 (0±9)
MDD 5±4 (1±1) 2±4 (0±7) 3±7 (0±8) 4±7 (1±0) 9±1 (1±3)
Mild 0±8 (0±4) 0±5 (0±3) 1±7 (0±6) 2±6 (0±7) 2±5 (0±7)
Moderate 2±3 (0±7) 1±0 (0±4) 1±2 (0±5) 1±2 (0±5) 3±4 (0±8)
Severe 2±4 (0±8) 1±0 (0±5) 0±7 (0±4) 0±8 (0±4) 3±2 (0±9)
Dysthymia 1±1 (0±4) 0±9 (0±3) 1±2 (0±5) 1±4 (0±5) 2±3 (0±6)
Any (including subthreshold) 10±7 (1±4) 5±8 (1±0) 4±1 (0±9) 7±5 (1±2) 14±8 (1±6)
Females (N¯ 609)
Subthreshold MDD 6±1 (1±0) 4±6 (0±9) 3±1 (0±7) 4±1 (0±8) 7±9 (1±2)
MDD 8±0 (1±2) 4±5 (0±9) 7±5 (1±2) 8±9 (1±3) 15±4 (1±6)
Mild 1±4 (0±6) 0±9 (0±5) 1±9 (0±6) 2±2 (0±6) 3±0 (0±8)
Moderate 2±5 (0±7) 1±2 (0±4) 2±8 (0±7) 3±3 (0±8) 5±0 (0±9)
Severe 4±0 (0±9) 2±4 (0±7) 2±8 (0±7) 3±3 (0±8) 7±3 (1±2)
Dysthymia 2±3 (0±6) 2±3 (0±6) 2±4 (0±7) 2±8 (0±8) 4±7 (0±9)
Any (including subthreshold) 15±3 (1±6) 10±2 (1±3) 10±0 (1±3) 14±8 (1±6) 25±3 (1±9)
LT, lifetime.
Because of the hierarchical nature of subthreshold and threshold MDD, and of mild, moderate and severe MDD, for these categories the
cumulative lifetime incidence may not equal the sum of the lifetime prevalence at baseline plus the incidence.
prevalence estimate of 8±0%. The overall 20-
month incidence rate was 7±1%, with a relatively
higher incidence of dysthymia and MDD than
of subthreshold MDD. In part, the stronger
increase of MDD as compared to subthreshold
MDD during the follow-up period may be due
to the fact that baseline subthreshold MDD
could develop into follow-up MDD, but not vice
versa. By prorating the 20-month incidence, we
can get a rough estimation of the 12-month
incidence, which is 4±3% overall (subthreshold
MDD 1±3%, MDD 3±4%, dysthymia 1±1%).
The female-to-male ratio of any depressive
disorder increased from 1±4 (χ#
"
¯ 5±69, P¯
0±02) at baseline to 1±7 (χ#
"
¯ 20±9, P! 0±01) at
follow-up. Hence overall, depression was more
prevalent among females, and the gender differ-
ence seemed to increase between baseline and
follow-up. The overall cumulative incidence at
follow-up indicates that 20±0% of the sample
had fulfilled criteria for at least one (sub-
threshold) depressive condition, with a pre-
ponderance of MDDs, both in males (9±1% of a
total of 14±8%) and in females (15±4% of a total
of 25±3%). It is remarkable that only a minority
of the MDDs were mild, and over 40% were
severe, i.e. had several symptoms in excess of
those required for the diagnosis and marked
interference with occupational or social func-
tioning. Despite the young age of the sample,
12% of the MDDs were recurrent (males 8%,
females 15%, χ#
"
¯ 1±47, P¯ 0±22).
Age of onset
Fig. 1 represents cumulative hazards, for both
baseline and follow-up findings. The baseline
and follow-up curves largely overlap before the
age of 14, suggesting considerable consistency of
the age-of-onset reports (Wittchen et al. 1998d ).
The cumulative hazard functions of all three
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F. 1. Age of onset curves (cumulative incidences) of depressive conditions, by gender (_, male ; E, female), baseline (——)
and follow-up (– – – – –) estimates.
diagnoses indicate consistently that onset prior
to the age of 12 is rare, with a fairly strong and
steadily rising cumulative incidence after the age
of 13 for MDD. The increase in gender
differences was examined by repeated measures
analysis of variance (ANOVA) on the lifetime
rates of depression, with gender as between-
subjects factor and age as within-subjects factor
(using unweighted data). Although ANOVA
assumes normally distributed variables, it pro-
duces reasonably accurate probability state-
ments for dichotomous data (Winer, 1971). The
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Table 3. Clinical outcome characteristics at follow-up among those with a lifetime diagnosis of
depression at baseline, weighted estimates (N¯ 1228)
Diagnosis at baseline
No. depr.
condition
(N¯ 1069)
Subthr. MDD
(N¯ 65)
MDD
(N¯ 82)
Dysthymia
(N¯ 21)
Outcome at follow-up % (..) % (..) % (..) % (..)
Number of periods† with depressed mood,
lack of energy or loss of interest
1 21±1 (1±4) 32±5* (6±7) 36±7* (6±1) 45±9* (10±9)
" 1 7±8 (0±9) 19±7* (5±3) 26±1* (5±8) 39±0* (10±7)
Impairment due to depr. symptoms‡
Some 9±1 (1±0) 17±2* (4±9) 19±8* (5±4) 15±3* (6±7)
Considerable 7±3 (0±9) 23±7* (5±7) 29±3* (5±8) 45±6* (10±9)
Days unable to work§ in last 4 weeks
At least one 2±5 (0±5) 8±8* (3±2) 9±9* (3±5) 31±4* (10±3)
12-month diagnosis at follow-up
Completely remitted}no depr. symptoms 81±3 (1±3) 53±8* (6±7) 42±7* (6±3) 33±3* (10±3)
Partially remitted}symptomatic 10±8 (1±1) 20±0 (5±4) 19±5* (4±8) 14±3 (6±7)
Subthreshold MDD 2±2 (0±4) 4±6 (2±9) 11±1* (4±6) 4±8 (3±3)
MDD 4±9 (0±7) 18±8* (5±3) 18±3* (4±8) 28±6* (9±9)
Dysthymia 1±3 (0±4) 4±6* (2±5) 9±8* (4±0) 23±8* (9±7)
Bipolar disorder 0±9 (0±3) 3±1 (1±8) 3±7* (2±6) 0±0 (0±0)
Suicidal ideation 3±6 (0±6) 11±5* (4±2) 10±4* (3±5) 25±5* (10±2)
Suicide attempt 0±7 (0±3) 2±9 (2±8) 4±4* (2±7) 17±3* (9±5)
Received professional help 3±4 (0±6) 11±9* (4±4) 7±6 (3±0) 22±5* (6±1)
† Periods of at least 2 weeks, with at least one of these symptoms present almost every day, during most part of the day.
‡ Both overall and social-role-specific impairment, which could be scored as none, a little, some, and a lot (¯ considerable).
§ Number of days unable to do daily activities (school, work) because of psychological symptoms.
* Significant (P! 0±05) difference with the group with no depressive condition at baseline, based on logistic regression analysis.
ANOVA yielded significant main and inter-
action effects for gender and age (linear contrast)
for all depressive conditions (subthreshold
MDD, gender F(1, 1226)¯ 7±0, P! 0±01, age
F(1, 1226)¯ 57±6, P! 0±01; interaction F(1,
1226)¯ 8±9, P! 0±01; MDD gender F(1, 1226)
¯ 17±4, P! 0±01, age F(1, 1226)¯ 96±2, P!
0±01, interaction F(1, 1226)¯ 12±1, P! 0±01;
dysthymia, gender F(1, 1226)¯ 5±0, P¯ 0±03,
age F(1, 1226)¯ 16±0, P! 0±01, interaction F(1,
1226)¯ 5±8, P¯ 0±02). The coefficients of the
interaction parameters indicated that differences
between males and females increased with age.
At baseline, there were no significant gender
differences in age of onset for subthreshold
MDD (t value, 0±64, P¯ 0±52), or for MDD (t
¯ 0±73, P¯ 0±47) or dysthymia (t¯ 1±49, P¯
0±15). At follow-up, however, the gender differ-
ences in the age of onset of MDD reached
statistical significance (mean age of onset males
17±3, females 16±5, t¯ 2±13, P¯ 0±04).
Clinical outcome characteristics
The probability of unfavourable outcomes was
significantly elevated in cases with any baseline
depression as compared to those unaffected at
baseline (Table 3). In general, MDD cases had
more unfavourable outcomes than subthreshold-
MDD cases, and the outcome pattern of
dysthymia was consistently the least favourable
one. All three groups were significantly more
likely than those unaffected at baseline to have
additional or continued episodes of depressed
mood, lack of energy or loss of interest : 52±2%
of the subthreshold MDD group, 62±8% of
those with MDD and 84±9% of the dysthymia
cases as compared to only 29±0% in the
unaffected group reported having had at least
one such episode during follow-up. Besides, all
baseline diagnostic groups were (significantly)
more likely to report considerable psychosocial
impairments due to depressive symptoms, and
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Table 4. Depression (lifetime) at baseline versus depressive status (12-month) at follow-up. Total
percentages, and conditional probabilities (counts in parentheses), weighted estimates
Depression symptoms and diagnostic status at follow-up
None Symptomatic Subthreshold Threshold Total
Depression symptoms and
diagnostic status at baseline
None
% of total 63±5% 8±1% 1±4% 3±8% 76±9%
Cond. prob. 82±6% 10±6% 1±8% 5±0% 100%
(N ) (780) (100) (17) (47) (944)
Symptomatic
% of total 7±2% 1±2% 0±2% 1±4% 10±1%
Cond. prob. 71±8% 12±1% 2±4% 13±7% 100%
(N ) (89) (15) (3) (17) (124)
Subthreshold
% of total 2±8% 1±0% 0±2% 0±9% 4±9%
Cond. prob. 56±7% 20±0% 5±0% 18±3% 100%
(N ) (34) (12) (3) (11) (60)
Threshold
% of total 3±4% 1±5% 0±7% 2±4% 8±1%
Cond. prob. 42±0% 19±0% 9±0% 30±0% 100%
(N ) (42) (19) (9) (30) (99)
Total
% of total 77±0% 11±9% 2±6% 8±6% 100%
(N ) (945) (146) (32) (105) (1228)
had more work-loss days in the month before
follow-up. Complete remissions, defined as not
having endorsed any of the depression stem
questions (feeling depressed or lost interest for 2
weeks or more during the 12 months preceding
the follow-up interview), were found in only
53±8% of the subthreshold, and 42±7% (MDD)
and 33±3% (dysthymia) of the threshold baseline
cases. Baseline dysthymia cases had the least
favourable outcome; 28±6% developed an MDD
and 23±8% met full dysthymia criteria again at
follow-up. A baseline diagnosis of any depressive
condition also significantly increased the prob-
ability of reporting suicidal ideation and suicide
attempts. The probability of suicidal ideation
was highest (25±5%) for those with a baseline
diagnosis of dysthymia; 17±3% of the baseline
dysthymia cases actually attempted suicide.
Despite this unfavourable picture, only 7±6–
12±5% of baseline depression cases reported
having received any type of professional help
(including a wide range of services such as help
services for children and parents, school psy-
chologists, general practitioners and telephone
help services, which are specifically probed in
the health service utilization section of the M-
CIDI), irrespective of type, duration or ad-
equacy. Among those with dysthymia, the
outcomes of persons with double depression, i.e.
both dysthymia and MDD, was particularly
unfavourable. But also pure baseline dysthymia
cases (without co-morbid MDD, N¯ 15) were
more likely to experience other episodes with
depressive symptoms (78±9%), to report some or
considerable impairment (50±0%), to be unable
to do daily activities (26±7%), or to consider
(28±6%) or attempt (28±6%) suicide than other
depressive conditions. Compared to double
depression, however, pure dysthymia cases had
a higher probability of complete remission
(46±7%).
Baseline by follow-up depression diagnostic
status across boundaries of specific disorders
Since dysthymia overlaps with (subthreshold)
MDD, Table 4 cross-tabulates the overall
outcome and stability findings on four levels of
depression symptoms and diagnostic status,
across boundaries of specific depressive dis-
orders, at baseline and at follow-up. The first
column in Table 4 indicates that the conditional
probability of being well at follow-up, thus of
reporting no significant signs of depression,
decreased monotonically from 82±6% among
asymptomatic baseline respondents, over 71±8%
in symptomatic and 56±7% in subthreshold
baseline cases, to a low of 42±0% among
threshold baseline cases. Similarly, the con-
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ditional probability of being a threshold case of
depression at follow-up, increased from a low of
5±0% in the asymptomatic baseline group to a
high of 30±0% in the baseline threshold group.
Similar systematic patterns can be seen for the
categories in between.
The stability of being at least symptomatic
was 41±1%. Subthreshold MDD was the least
stable diagnosis ; only 5±0% of the respondents
with a baseline subthreshold MDD had the
same diagnosis at follow-up. Baseline symp-
tomatic depression increased the likelihood of a
follow-up threshold diagnosis about 2±5-fold,
compared to respondents without any baseline
depressive symptomatology. It is noteworthy
that the probability of change between baseline
and follow-up increased with increasing length
of follow-up interval ; 30% of the probands with
an interval up to 19 months changed between
baseline and follow-up, versus 35% of the
probands with a follow-up period of 20 months
or more. However, the average length of follow-
up did not differ much between the various
levels of depressive symptomatology at baseline
(none, 19±6 months; symptomatic, 20±0 months;
subthreshold, 19±7 months; threshold, 20±3
months) and the effect of length of follow-up
period on the probability of change was the
same for all categories (no significant interaction
effects). We further examined whether the
likelihood of a (subthreshold or threshold)
depression at follow-up, given a depression at
baseline, was related to gender, age, or severity
of depression at baseline. Although the results
suggest (P! 0±10) that depression was more
persistent for older respondents with a higher
severity at baseline, none of these factors
predicted depression at a statistically significant
level.
Subthreshold depression: not meeting criterion
A versus not meeting criterion C
Subthreshold MDD was defined as falling short
of either the DSM-IV criterion of at least five
symptoms (Subthresh}Sx), or the criterion of
significant impairment (Subthresh}Imp). Sub-
thresh}Sx (i.e. four instead of at least five
symptoms) was relatively more frequent at
baseline measurement (12-month prevalence
2±4% versus 1±1% for Subthresh}Imp), whereas
Subthresh}Imp was more prevalent at follow-up
(12-month prevalence 1±6% versus 1±3% for
Subthresh}Sx). The cumulative lifetime incid-
ences were about equal (Subthresh}Sx, 3±1%;
Subthresh}Imp, 3±3%). Subthresh}Sx did not
differ from Subthresh}Imp with regard to mean
age of onset (baseline, t¯®0±38, P¯ 0±71;
follow-up t¯ 1±01, P¯ 0±32). However, persons
not meeting the criterion of at least five
symptoms at baseline (Subthresh}Sx) had sig-
nificantly more often one or more periods of
depressed mood (65±0% versus 32±0%, χ#
"
¯
6±72, P¯ 0±01), and considerable impairment
(32±5% versus 8±0%, χ#
"
¯ 5±20, P¯ 0±02) be-
tween baseline and follow-up. Furthermore,
fewer of the Subthresh}Sx-group had remitted
completely (40±0% versus 76±0%, χ#
"
¯ 8±02, P
! 0±01) and more of them had a diagnosis of
MDD (30±0% versus 4±0%, χ#
"
¯ 6±50, P¯ 0±01)
at follow-up. In fact, in terms of clinical outcome
characteristics Subthresh}Sx depressions closely
resembled threshold MDD: there were no
significant differences between the two groups
on either of the clinical outcome characteristics
listed in Table 3. On the other hand, persons not
meeting the impairment-criterion (Subthresh}
Imp) did not differ significantly from people
with no depressive condition on any of the
clinical outcome characteristics. Similarly, the
stability estimates for Subthresh}Sx were com-
pletely comparable to those for threshold de-
pression, and the estimates for Subthresh}Imp
were of the order of the magnitude of the
estimates for no and symptomatic depression.
DISCUSSION
The main aim of this paper was to estimate
prevalence and incidence of several depressive
conditions, and to investigate age-of-onset char-
acteristics and 20-month outcome. Largely con-
sistent with other studies, our results reveal that
depressive disorders (MDD and dysthymia) as
defined by M-CIDI}DSM-IV criteria are quite
prevalent in adolescents, affecting about 14% of
the sample and 20% if including subthreshold
MDD. It is noteworthy that our estimated rates
for MDD and dysthymia are well within the
range of those found in a number of other recent
population-based studies among adolescents and
young adults, summarized in Table 5.
Although we could speculate to what degree
the differences in rates might be a reflection of
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Table 5. Prevalence and incidence rates of major depression and dysthymia in a number of
population-based studies
Study, area Age Time frame MDD Dysthymia
EDSP, Munich, Germany (this paper) 15–19 Lifetime 12±2% 3±5%
OADP, Oregon (Lewisohn et al. 1993) 15–19 Lifetime 24±0% 3±0%
NCS, USA (Kessler et al. 1994, Blazer et al. 1994) 15–24 Lifetime 15±7% —
USA (Whittaker et al. 1990) 14–17 Lifetime 4±0% 4±0%
EDSP, Munich Germany (this paper) 15–19 12-month 6±8% 2±1%
DMHDS, Dunedin, New Zealand (Feehan et al. 1994) 18 12-month 16±7% —
NCS, USA (Kessler et al. 1994) 15–24 12-month 12±8% —
OHS, Ontario (Offord et al. 1996) 15–24 12-month 5±1% 3±2%
CHDS, Christchurch, New Zealand (Fergusson et al. 1993) 15 12-month 4±2%* 0±4%*
The Netherlands (Verhulst et al. 1997) 13–18 6-month 2±8%* 1±5%*
EDSP, Munich, Germany (this paper) 15–19 12-month incidence 3±4%† 1±1%†
OADP, Oregon (Lewinsohn et al. 1993) 15–19 12-month incidence 5±7% 0±1%
* Based on adolescents’ self-reports.
† Estimated by prorating the 20-month incidence.
ESCP, Early Developmental Stages of Psychopathology; OADP, Oregon Depression Project ; NCS, National Comorbidity Survey;
DMHDS, Dunedin Multidisciplinary Health and Development Study; OHS, Ontario Health Survey; CHDS, Christchurch Health and
Development Study.
variations in risk constellations in the respective
populations, we rather assume that they are
largely a result of design features, such as the
sample selection, age distribution and diagnostic
interview. We also confirm that depressive
disorders in this age group: (a) are more frequent
in females and that this difference gets larger
with increasing age; (b) rarely start before the
age of 13; and (c) are poorly treated, even in a
comprehensive health care system offering any
type of medical and psychological therapy free
of charge. The low treatment rates found in this
study are consistent with reports from the UK
(Goodyer & Cooper, 1993), USA (Whittaker et
al. 1990), Canada (Links et al. 1989) and New
Zealand (Fergusson et al. 1993). Comparison of
several age groups with respect to treatment
rates for MDD in Germany revealed that the
probability of treatment increased with age,
treatment rates were low overall, but particularly
low in young people (Wittchen et al. 1999).
Beyond previous studies, we demonstrated
that : (a) only few (23%) MDDs in adolescence
are mild in terms of number and severity of
symptoms, whereas many 43% are classified as
severe ; and that (b) subthreshold MDD has
almost identical age-of-onset characteristics as
MDD (irrespective of whether the symptoms did
not meet criterion A or criterion C). Hence,
although we did find that subthreshold disorders
were relatively more frequent in younger re-
spondents, we failed to confirm the hypothesis
that they are more likely to have an onset in
childhood. Both threshold and subthreshold
disorders are relatively rare before the age of 13,
affecting only about 2% of the population in
childhood.
Age of onset
We found consistently that onset prior to the
age of 12 was relatively rare, with a fairly strong
and steadily rising cumulative incidence after
the age of 13 for MDD. The age-of-onset curves
of MDD largely resemble those presented by
Lewinsohn et al. (1992), except for the scale of
the Y-axis : our cumulative incidences are con-
siderably lower. We estimated separate age-of-
onset curves for baseline and follow-up reports.
The curves largely overlapped before the age of
14, suggesting a sufficient reliability of the age-
of-onset information in terms of consistency of
report. This is better than might be expected on
the basis of previous reports, which suggested
that recall of dates of onset of symptoms over
periods of more than a few months may be
subject to a great deal of error (Angold et al.
1996). The high consistency of the age-of-onset
information given by the respondent over a
period of more than one and a half years may be
a result of the detailed way it is assessed in the
M-CIDI, which uses cognitive aids to stimulate
memory search for the first occurrence of key
features of the condition and separate summary
questions to assess when the respondent met the
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full set of diagnostic criteria (Wittchen et al.
1998d ).
Natural course
Given the stereotype that adolescent depressive
disorders are frequently mild and short-lived,
our results regarding the natural course of
adolescent depression revealed an unexpectedly
unfavourable outcome pattern. Complete re-
mission was found in only 54% of those with
subthreshold MDD, 43% of those with
threshold MDD and 33% of the baseline
dysthymia cases. Baseline dysthymia cases had
the least favourable outcome; 29% developed a
MDD and 24% met full dysthymia criteria
again at follow-up. Persistence of depression at
follow-up seemed to be related to higher age and
severity of depression at baseline. These findings
are similar to those found in a sample of 8–16-
year-old mental health care out-patients
(Goodyer et al. 1997). The unfavourable out-
come of cases with dysthymia is in line with
previous findings (e.g. AACAP, 1998). It is
notable that this outcome was only partly
influenced by cases with double depression, who
had the least favourable outcome pattern of all,
and that even dysthymic adolescents without
MDD had low (! 50%) chances of recovery,
frequently (50%) reported psychosocial impair-
ments due to depressive symptoms during
follow-up, as well as suicide attempts (29%).
One possible explanation may be that early-
onset dysthymic disorder is a forerunner of
recurrent affective illness (Kovacs et al. 1994).
Our data support the idea that dysthymia is
milder in terms of symptomatology but has a
more chronic course (Klein et al. 1998) and
higher impairment rates (Whittaker et al. 1990),
suggesting that duration may be at least at
important as symptom severity.
Subthreshold forms of depression
In this study, the outcome of adolescents with
four depressive symptoms and impairments was
just as unfavourable as the outcome of those
with five symptoms or more (i.e. MDD). When
the symptoms did not meet the impairment (or
distress) criterion, the outcome was not or hardly
more unfavourable than that of persons without
a depressive condition. Hence, our results
support the recommendations by Roberts et al.
(1998) and Costello et al. (1996b) to use both
symptom and impairment criteria when deter-
mining caseness. On the other hand, the A-
criterion for MDD, requiring at least five
symptoms, seems to be arbitrary, at least in this
adolescent sample. Strict application of this rule
might lead to underestimation of the amount of
severe depressive symptomatology in ado-
lescents.
This study has noteworthy limitations. The
interpretation of our findings is limited by the
fact that we did not report the effect of co-
morbidity with other DSM-IV disorders on the
probability, severity and persistence of de-
pression. We acknowledge that co-morbidity
may largely affect the course and outcome of
adolescent depression (e.g. Kovacs et al. 1989;
Harrington et al. 1991; Birmaher et al. 1996;
Goodyer et al. 1997). We also refrained from
reporting any details on (putative) risk factor of
adolescent depression. The complexity of these
mechanisms requires them to be dealt with in a
separate paper. The information gathered in this
study was obtained exclusively from the ado-
lescents themselves. Since many parents of
14–19-year-olds will not be completely informed
about their childrens’ thoughts and emotions,
adolescent self-report is essential for the study of
emotional disorders (Whittaker et al. 1990).
Although additional information from parents
and teachers may provide further insight, parent
reports and adolescent self-reports of affective
disorders have been found to have little overlap
between them (Fleming et al. 1989; Cantwell et
al. 1996; Verhulst et al. 1997) and are hence
difficult to interpret. We feel confident about our
procedure because M-CIDI diagnoses have been
found to be as reliable and valid in adolescent
and young adults as in older respondents
(Wittchen & Pfister, 1997).
Our data suggest that DSM-IV MDD and
dysthymia are frequent adolescent disorders,
with an estimated lifetime cumulative incidence
of 14%, that they are rare before the age of 13,
that more than half of them persist or remit only
partly during a 20-month follow-up period, and
that only a minority is treated professionally.
Although this study did not investigate the
resulting impairment in various roles and
domains in detail, the indicators used point to
the potential importance of these disorders in a
key developmental phase of life, in which critical
choices are made in terms of personal relation-
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ships and professional career. To what extent
these choices are affected by depressive symp-
tomatology should be studied in the future.
Furthermore, continued research emphasis
should be given to subthreshold forms of MDD
and their implications for optimal diagnostic
algorithms for adolescents.
We would like to thank Johan Ormel for his helpful
comments.
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